These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8993503)

  • 1. The cell cycle effects of camptothecin.
    Darzynkiewicz Z; Bruno S; Del Bino G; Traganos F
    Ann N Y Acad Sci; 1996 Dec; 803():93-100. PubMed ID: 8993503
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis.
    Johnson N; Ng TT; Parkin JM
    Leuk Res; 1997 Oct; 21(10):961-72. PubMed ID: 9403007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular resistance to camptothecins.
    Pommier Y; Gupta M; Valenti M; Nieves-Neira W
    Ann N Y Acad Sci; 1996 Dec; 803():60-73. PubMed ID: 8993501
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of apoptosis by camptothecin and topotecan.
    Traganos F; Seiter K; Feldman E; Halicka HD; Darzynkiewicz Z
    Ann N Y Acad Sci; 1996 Dec; 803():101-10. PubMed ID: 8993504
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
    Morris EJ; Geller HM
    J Cell Biol; 1996 Aug; 134(3):757-70. PubMed ID: 8707853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human cell multiprotein DNA replication complex (MRC): the effect of camptothecin on its ability to support in vitro DNA synthesis.
    Coll JM; Hickey RJ; Wei Y; Malkas LH
    Cancer Chemother Pharmacol; 1996; 39(1-2):97-102. PubMed ID: 8995505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin resistance related to drug-induced down-regulation of topoisomerase I and to steps occurring after the formation of protein-linked DNA breaks.
    Murren JR; Beidler DR; Cheng YC
    Ann N Y Acad Sci; 1996 Dec; 803():74-92. PubMed ID: 8993502
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of DNA replication in camptothecin-treated cells is regulated by protein kinases.
    Zhou XY; Wang Y
    Ann N Y Acad Sci; 2000; 922():355-9. PubMed ID: 11193922
    [No Abstract]   [Full Text] [Related]  

  • 11. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse effect of topoisomerase I specific inhibitor (camptothecin) on normal and BCR/ABL-dependent hematopoietic cells proliferation: therapeutic implications.
    Fertała J; Nieborowska-Skórska M; Calabretta B; Skórski T
    Folia Histochem Cytobiol; 1995; 33(3):187-92. PubMed ID: 8612872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].
    Tsunoda T
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():472-5. PubMed ID: 14574938
    [No Abstract]   [Full Text] [Related]  

  • 14. The homocamptothecin, BN 80927, is a potent topoisomerase I poison and topoisomerase II catalytic inhibitor.
    Demarquay D; Coulomb H; Huchet M; Lesueur-Ginot L; Camara J; Lavergne O; Bigg D
    Ann N Y Acad Sci; 2000; 922():301-2. PubMed ID: 11193906
    [No Abstract]   [Full Text] [Related]  

  • 15. Ubiquitin, SUMO-1, and UCRP in camptothecin sensitivity and resistance.
    Desai SD; Mao Y; Sun M; Li TK; Wu J; Liu LF
    Ann N Y Acad Sci; 2000; 922():306-8. PubMed ID: 11193908
    [No Abstract]   [Full Text] [Related]  

  • 16. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT; Bertrand R
    Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of camptothecin treatment on topoisomerase II alpha expression in ML-1 and HL-60 leukemia cell lines.
    Nair J; Traganos F; Tse-Dinh YC
    Anticancer Res; 2000; 20(6B):4183-8. PubMed ID: 11205246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of resistance to camptothecins.
    Saleem A; Edwards TK; Rasheed Z; Rubin EH
    Ann N Y Acad Sci; 2000; 922():46-55. PubMed ID: 11193924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells.
    Goossens JF; Hénichart JP; Dassonneville L; Facompré M; Bailly C
    Eur J Pharm Sci; 2000 Apr; 10(2):125-31. PubMed ID: 10727878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of topoisomerase I mutations affecting both DNA cleavage and interaction with camptothecin.
    Li XG; Haluska P; Hsiang YH; Bharti A; Kufe DW; Rubin EH
    Ann N Y Acad Sci; 1996 Dec; 803():111-27. PubMed ID: 8993505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.